Opus Genetics, Inc.

IRD ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2001
Assets
Cash & Equivalents
Accounts Receivable
Inventory
Total Current Assets
Property, Plant & Equipment
Goodwill
Intangible Assets (Excl. Goodwill)
Total Assets
Liabilities
Accounts Payable
Total Current Liabilities
Long-Term Debt
Total Liabilities
Stockholders' Equity
Retained Earnings
Total Stockholders' Equity $3.9M
← Newer Page 4 of 4 Older →